- Home
- YYAI vs PYPD Comparison
YYAI vs PYPD Comparison
Compare YYAI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYAI
- PYPD
- Stock Information
- Founded
- YYAI 2015
- PYPD 2008
- Country
- YYAI United States
- PYPD Israel
- Employees
- YYAI N/A
- PYPD N/A
- Industry
- YYAI
- PYPD Medical/Dental Instruments
- Sector
- YYAI
- PYPD Health Care
- Exchange
- YYAI NYSE
- PYPD Nasdaq
- Market Cap
- YYAI 19.5M
- PYPD 16.5M
- IPO Year
- YYAI N/A
- PYPD 2020
- Fundamental
- Price
- YYAI $1.03
- PYPD $2.93
- Analyst Decision
- YYAI
- PYPD Strong Buy
- Analyst Count
- YYAI 0
- PYPD 2
- Target Price
- YYAI N/A
- PYPD $12.00
- AVG Volume (30 Days)
- YYAI 539.5K
- PYPD 28.7K
- Earning Date
- YYAI 12-24-2024
- PYPD 02-12-2025
- Dividend Yield
- YYAI N/A
- PYPD N/A
- EPS Growth
- YYAI N/A
- PYPD N/A
- EPS
- YYAI N/A
- PYPD N/A
- Revenue
- YYAI N/A
- PYPD N/A
- Revenue This Year
- YYAI N/A
- PYPD N/A
- Revenue Next Year
- YYAI N/A
- PYPD N/A
- P/E Ratio
- YYAI N/A
- PYPD N/A
- Revenue Growth
- YYAI N/A
- PYPD N/A
- 52 Week Low
- YYAI $0.95
- PYPD $2.37
- 52 Week High
- YYAI $53.00
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- YYAI 22.69
- PYPD 33.37
- Support Level
- YYAI $0.97
- PYPD $2.37
- Resistance Level
- YYAI $1.47
- PYPD $3.13
- Average True Range (ATR)
- YYAI 0.17
- PYPD 0.24
- MACD
- YYAI 0.06
- PYPD -0.06
- Stochastic Oscillator
- YYAI 14.26
- PYPD 19.30
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.